Description
365 ginkgo biloba 6000 mg tablets – Premium extract from Vit4ever
Product description
The 365 ginkgo biloba 6000 mg Vit4ever tablets offer a high-dose premium extract with flavone glycosides and ginkgolide terpene lactones, free from ginkgolic acid. This vegan dietary supplement is laboratory-tested and supports cognitive performance and blood circulation.
Ginkgo biloba has been valued for centuries for its effects on the brain and blood circulation. The extract in these tablets is particularly pure and contains no undesirable ginkgolic acids, which can cause allergic reactions.
This product is ideal for people who want to improve their mental clarity and focus while benefiting from a high-dose, safe, and vegan product.
For holistic inner support we recommend the raw Yemeni Sidr Doani honeywhich provides valuable nutrients.
Further information on the effects of Ginkgo Biloba can be found on the website of the Federal Center for Nutrition (bzfe.de).
product advantages
- 
365 vegan ginkgo biloba 6000 mg tablets with premium extract
 - 
Contains flavonglycosides and ginkgolide terpene lactones
 - 
Free from allergenic ginkgolic acid
 - 
Laboratory-tested, high-dose and vegan
 - 
Supports cognitive functions and blood circulation
 
Application
Daily recommended ginkgo biloba 6000 mg Take tablets with plenty of water, preferably with meals.
Product details
Contents: 365 tablets
Dosage: 6000 mg Premium Ginkgo Biloba extract per tablet
Ingredients: Flavonglycosides, ginkgolide terpene lactones
Free from: Ginkgolic acid
Form: Vegan tablets
Laboratory tested: Yes
Manufacture: Germany
storage
Store in a cool, dry place, protected from light. Keep out of reach of children.
sustainability
Vegan, without artificial additives, sustainably produced.
Conclusion
The 365 ginkgo biloba 6000 mg Vit4ever tablets are a high-dose premium extract to support cognitive performance and blood circulation – vegan, laboratory-tested, and free of ginkgolic acid.
		
								
								













  
  






Reviews
There are no reviews yet.